ARCHIVES

Dendritic Cell Vaccine Increases PFS in Phase II Clinical Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Government Shutdown Cancels NCI Site Visit To Mayo Cancer Center

October 11, 2013

Centers Form Big Ten Research Consortium with Access to Over 30,000 New Patients a Year

May 31, 2013

Bristol-Myers Awards 42.5 Million In Cancer Grants

October 21, 1977

In Brief: Greenwald Named Director, NCI Prevention; Wells Directs American College Of Surgeons

June 19, 1998

FDA Grants Accelerated Approval To Mekinist-Tafinlar Combination

January 31, 2014

NTP Board Approves Four New Concepts

October 8, 1982